True North Therapeutics

True North Therapeutics

True North Therapeutics

True North Therapeutics is a pioneering biotechnology company selectivelyinhibiting the Complement pathway for diseases.
Founded
2013
Raised
$102M
Follow us
Alexa global traffic share
Acquired by
Bioverativ
1
23 May 2017
$400,000,000
Latest funding Show all
$35,000,000
Venture capital (Series B) - 2015
Kleiner Perkins Caufield & Byers SR One MPM Capital +2
$400,000,000
Xconomy

Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North

Health Strategy
$45,000,000 Venture capital (Series D)
FinSMEs

True North Therapeutics Closes $45M Series D Financing

Funding Health